D. M. Hart

No ORCID on file · 7 papers in corpus
article 1996
European Journal of Obstetrics & Gynecology and Reproductive Biology ·doi:10.1016/0301-2115(95)02378-x

The gonadomimetic steroid Tibolone, is currently widely used for the treatment of menopausal symptoms. Up to 20% of women have been reported to have episodes of bleeding whilst on therapy. We investigated 37 cases who experienced bleeding e…

article 1992
Acta endocrinologica ·doi:10.1530/acta.0.1270123

GnRH agonists can induce a reversible pharmacological menopause and can be used to treat endometriosis, a fairly common gynaecological problem which responds well to oestrogen deprivation. Premature menopause is associated with adverse lipi…

article 1991
·doi:10.1136/pgmj.67.787.450

Summary This double-blind, randomized, crossover study compared the efficacy and safety of danazol (100 mg twice daily) with matching placebo in the treatment of severe premenstrual syndrome. Nineteen patients were randomly allocated to rec…

article 1991
·doi:10.1016/0378-5122(91)90199-z

Long-term therapy with (7 alpha,17 alpha)-17-hydroxy-7-methyl-19-norpregn-5(10)-en-20-yn-3-one (Org OD 14; tibolone, Livial) has no influence on the endometrium in post-menopausal women. This was concluded from endometrial biopsies taken fr…

article 1989
·doi:10.3109/01443618909151073

SummaryA double blind placebo controlled cross over study was conducted to assess the response of women with severe premenstrual syndrome to treatment with danazol. Daily self assessment of clinical state was measured using the Moos menstru…

article 1985
·doi:10.1016/0022-4731(85)90354-1
article 1985
·doi:10.1177/030006058501300210

Introduction Danol (danazoI) is a synthetic steroid which has been found to be effective in the treatment of a variety of gynaecological and endocrinological disorders including endometriosis (Young & Blackmore 1977), fibroadenosis (Mansel …